Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225 - 49; http://dx.doi.org/10.3322/caac.20006; PMID: 19474385
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893 - 917; http://dx.doi.org/10.1002/ijc.25516; PMID: 21351269
   PubMed Web of Science ®Google Scholar
• Zhang W, Glöckner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008; 68:2764 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-07-6349; PMID: 18413743
   PubMed Web of Science ®Google Scholar
• Riojas MA, Guo M, Glöckner SC, Machida EO, Baylin SB, Ahuja N. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer. Cancer Biol Ther 2007; 6:1710 - 6; http://dx.doi.org/10.4161/cbt.6.11.4829; PMID: 17986858
   PubMed Web of Science ®Google Scholar
• Hanada N, Takahata T, Zhou Q, Ye X, Sun R, Itoh J, Ishiguro A, Kijima H, Mimura J, Itoh K, et al. Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 2012; 12:66; http://dx.doi.org/10.1186/1471-2407-12-66; PMID: 22325485
   PubMed Web of Science ®Google Scholar
• Dallosso AR, Øster B, Greenhough A, Thorsen K, Curry TJ, Owen C, Hancock AL, Szemes M, Paraskeva C, Frank M, et al. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene 2012; 31:4409 - 19; http://dx.doi.org/10.1038/onc.2011.609; PMID: 22249255
   PubMed Web of Science ®Google Scholar
• Xu Y, Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007; 16:Spec No 1 R14 - 20; http://dx.doi.org/10.1093/hmg/ddl486; PMID: 17613544
   PubMedGoogle Scholar
• Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295 - 309; http://dx.doi.org/10.1016/S0092-8674(00)00121-5; PMID: 11057902
   PubMed Web of Science ®Google Scholar
• Azuma H, Ehata S, Miyazaki H, Watabe T, Maruyama O, Imamura T, Sakamoto T, Kiyama S, Kiyama Y, Ubai T, et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005; 97:1734 - 46; http://dx.doi.org/10.1093/jnci/dji399; PMID: 16333029
   PubMed Web of Science ®Google Scholar
• Leivonen SK, Ala-Aho R, Koli K, Grénman R, Peltonen J, Kähäri VM. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006; 25:2588 - 600; http://dx.doi.org/10.1038/sj.onc.1209291; PMID: 16407850
   PubMed Web of Science ®Google Scholar
• Leivonen SK, Kähäri VM. Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 2007; 121:2119 - 24; http://dx.doi.org/10.1002/ijc.23113; PMID: 17849476
   PubMed Web of Science ®Google Scholar
• Tian M, Schiemann WP. The TGF-beta paradox in human cancer: an update. Future Oncol 2009; 5:259 - 71; http://dx.doi.org/10.2217/14796694.5.2.259; PMID: 19284383
   PubMed Web of Science ®Google Scholar
• Kongkanuntn R, Bubb VJ, Sansom OJ, Wyllie AH, Harrison DJ, Clarke AR. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene 1999; 18:7219 - 25; http://dx.doi.org/10.1038/sj.onc.1203181; PMID: 10602475
   PubMed Web of Science ®Google Scholar
• Thorstensen L, Lind GE, Løvig T, Diep CB, Meling GI, Rognum TO, Lothe RA. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 2005; 7:99 - 108; http://dx.doi.org/10.1593/neo.04448; PMID: 15802015
   PubMed Web of Science ®Google Scholar
• Van der Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, Anti M, Van Gijn ME, Suijkerbuijk S, Van de Wetering M, Marra G, et al. The Intestinal Wnt/TCF Signature. Gastroenterology 2007; 132:628 - 32; http://dx.doi.org/10.1053/j.gastro.2006.08.039; PMID: 17320548
   PubMed Web of Science ®Google Scholar
• Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272:24735 - 8; http://dx.doi.org/10.1074/jbc.272.40.24735; PMID: 9312064
   PubMed Web of Science ®Google Scholar
• Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol 2001; 21:5132 - 41; http://dx.doi.org/10.1128/MCB.21.15.5132-5141.2001; PMID: 11438668
   PubMed Web of Science ®Google Scholar
• Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann’s organizer. Nature 2000; 403:781 - 5; http://dx.doi.org/10.1038/35001602; PMID: 10693808
   PubMed Web of Science ®Google Scholar
• Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007; 67:75 - 84; http://dx.doi.org/10.1158/0008-5472.CAN-06-2559; PMID: 17210685
   PubMed Web of Science ®Google Scholar
• Hussein SM, Duff EK, Sirard C. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 2003; 278:48805 - 14; http://dx.doi.org/10.1074/jbc.M305472200; PMID: 14551209
   PubMed Web of Science ®Google Scholar
• Letamendia A, Labbé E, Attisano L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 2001; 83-A:Suppl 1 S31 - 9; PMID: 11263663
   PubMedGoogle Scholar
• Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H, Foisner R. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 2004; 23:2672 - 80; http://dx.doi.org/10.1038/sj.onc.1207416; PMID: 14755243
   PubMed Web of Science ®Google Scholar
• Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y, Di Vizio D, Wang C, Lisanti MP, Sauter G, et al. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 2006; 26:7116 - 29; http://dx.doi.org/10.1128/MCB.00268-06; PMID: 16980615
   PubMed Web of Science ®Google Scholar
• Nan F, Lü Q, Zhou J, Cheng L, Popov VM, Wei S, Kong B, Pestell RG, Lisanti MP, Jiang J, et al. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol Ther 2009; 8:1534 - 9; http://dx.doi.org/10.4161/cbt.8.16.8963; PMID: 19502783
   PubMed Web of Science ®Google Scholar
• Wu K, Liu M, Li A, Donninger H, Rao M, Jiao X, Lisanti MP, Cvekl A, Birrer M, Pestell RG. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Mol Biol Cell 2007; 18:755 - 67; http://dx.doi.org/10.1091/mbc.E06-09-0793; PMID: 17182846
   PubMed Web of Science ®Google Scholar
• Yamada Y, Arao T, Gotoda T, Taniguchi H, Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, et al. Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci 2008; 99:2193 - 9; http://dx.doi.org/10.1111/j.1349-7006.2008.00935.x; PMID: 18957060
   PubMed Web of Science ®Google Scholar
• Wu K, Yang Y, Wang C, Davoli MA, D’Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, et al. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. J Biol Chem 2003; 278:51673 - 84; http://dx.doi.org/10.1074/jbc.M310021200; PMID: 14525983
   PubMed Web of Science ®Google Scholar
• Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, Pestell RG. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab 2010; 21:41 - 9; http://dx.doi.org/10.1016/j.tem.2009.08.002; PMID: 19896866
   PubMed Web of Science ®Google Scholar
• Kim SS, Zhang RG, Braunstein SE, Joachimiak A, Cvekl A, Hegde RS. Structure of the retinal determination protein Dachshund reveals a DNA binding motif. Structure 2002; 10:787 - 95; http://dx.doi.org/10.1016/S0969-2126(02)00769-4; PMID: 12057194
   PubMed Web of Science ®Google Scholar
• Hammond KL, Hanson IM, Brown AG, Lettice LA, Hill RE. Mammalian and Drosophila dachshund genes are related to the Ski proto-oncogene and are expressed in eye and limb. Mech Dev 1998; 74:121 - 31; http://dx.doi.org/10.1016/S0925-4773(98)00071-9; PMID: 9651501
   PubMed Web of Science ®Google Scholar
• Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res 2006; 66:8404 - 12; http://dx.doi.org/10.1158/0008-5472.CAN-06-0683; PMID: 16951150
   PubMed Web of Science ®Google Scholar
• Zhou B, Liu Y, Kahn M, Ann DK, Han A, Wang H, Nguyen C, Flodby P, Zhong Q, Krishnaveni MS, et al. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem 2012; 287:7026 - 38; http://dx.doi.org/10.1074/jbc.M111.276311; PMID: 22241478
   PubMed Web of Science ®Google Scholar
• Labbé E, Letamendia A, Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 2000; 97:8358 - 63; http://dx.doi.org/10.1073/pnas.150152697; PMID: 10890911
   PubMed Web of Science ®Google Scholar
• Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, Song LN, Tian L, Jin M, Pestell RG. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res 2009; 69:3347 - 55; http://dx.doi.org/10.1158/0008-5472.CAN-08-3821; PMID: 19351840
   PubMed Web of Science ®Google Scholar
• Liang F, Lü Q, Sun S, Zhou J, Popov VM, Li S, Li W, Liu Y, Jiang J, Kong B. Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome. Int J Gynecol Cancer 2012; 22:386 - 93; http://dx.doi.org/10.1097/IGC.0b013e31824311e6; PMID: 22367319
   PubMed Web of Science ®Google Scholar
• Dong Y, Drissi H, Chen M, Chen D, Zuscik MJ, Schwarz EM, O’Keefe RJ. Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta. J Cell Biochem 2005; 95:1057 - 68; http://dx.doi.org/10.1002/jcb.20466; PMID: 15962307
   PubMed Web of Science ®Google Scholar
• Minoo P, Li C. Cross-talk between transforming growth factor-beta and Wingless/Int pathways in lung development and disease. Int J Biochem Cell Biol 2010; 42:809 - 12; http://dx.doi.org/10.1016/j.biocel.2010.02.011; PMID: 20219694
   PubMed Web of Science ®Google Scholar
• Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A, Vancheri C. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 2008; 57:274 - 82; http://dx.doi.org/10.1016/j.phrs.2008.02.001; PMID: 18346908
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275:1787 - 90; http://dx.doi.org/10.1126/science.275.5307.1787; PMID: 9065402
   PubMed Web of Science ®Google Scholar
• Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58:1130 - 4; PMID: 9515795
   PubMed Web of Science ®Google Scholar
• Armand JP. [Focus on cellular pharmacology of docetaxel]. Bull Cancer 2003; 90:1067 - 70; PMID: 14715427
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821 - 6; http://dx.doi.org/10.1073/pnas.93.18.9821; PMID: 8790415
   PubMed Web of Science ®Google Scholar
• Jia Y, Yang Y, Liu S, Herman JG, Lu F, Guo M. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Epigenetics 2010; 5:743 - 9; http://dx.doi.org/10.4161/epi.5.8.13104; PMID: 20716954
   PubMed Web of Science ®Google Scholar
• Wu K, Yang Y, Wang C, Davoli MA, D’Amico M, Li A, Cveklova K, Kozmik Z, Lisanti MP, Russell RG, et al. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. J Biol Chem 2003; 278:51673 - 84; http://dx.doi.org/10.1074/jbc.M310021200; PMID: 14525983
   PubMed Web of Science ®Google Scholar